Pralsetinib - Blueprint Medicines/Roche
At a glance
- Drug Originator Blueprint Medicines
- Drug Licenced by Allist Pharmaceuticals; CStone Pharmaceuticals; Roche
- Drug Class Amides; Amines; Antineoplastics; Cyclohexanes; Ethers; Fluorinated hydrocarbons; Pyrazoles; Pyridines; Pyrimidines; Small molecules
- Mechanism of Action Proto oncogene protein c ret inhibitors
- USA Patent Applicants GENENTECH INC
- USA Patents 4
- NDAs 1
- International Patents 54
- Patent Applications 38

Disclaimer